Guarding against the most dangerous emerging pathogens

Emerging Infectious Diseases
Paul W Ewald

Abstract

Control of emerging infectious diseases will be difficult because of the large number of disease-causing organisms that are emerging or could emerge and the great diversity of geographic areas in which emergence can occur. The modern view of the evolution of pathogen virulence--specifically its focus on the tradeoff between costs and benefits to the pathogen from increased host exploitation--allows control programs to identify and focus on the most dangerous pathogens (those that can be established with high virulence in human populations).

References

Sep 1, 1978·American Journal of Diseases of Children·J J Gooch, E M Britt
Nov 1, 1978·Annals of Internal Medicine·R E Dixon
Oct 3, 1992·Lancet·J PuelA Berrebi
Jun 16, 1992·Annals of the New York Academy of Sciences·J A HouseC A Mebus
Dec 1, 1991·The American Journal of the Medical Sciences·T N Raju, C Kobler
Jan 1, 1990·Medical Microbiology and Immunology·K E SchneweisH H Brackmann
May 26, 1989·JAMA : the Journal of the American Medical Association·J A Levy
Feb 1, 1984·Journal of Medical Microbiology·B R LyonR A Skurray
Jan 1, 1984·Journal of Perinatal Medicine·F Daschner
Oct 1, 1982·Parasitology·R M Anderson, R M May
Nov 29, 1994·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·P W Ewald
Jan 26, 1995·The New England Journal of Medicine·F KirchhoffR C Desrosiers
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·J RelloR Rodriguez-Roisin
Aug 10, 1994·JAMA : the Journal of the American Medical Association·G Adjorlolo-JohnsonL Kestens
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·B WeiserH Burger
Feb 1, 1994·Medical Microbiology and Immunology·H SchmidtH Karch
Jan 15, 1994·International Journal of Cancer. Journal International Du Cancer·P H LevineW A Blattner
Sep 1, 1993·The Journal of Clinical Investigation·M S DonnenbergM M Levine
Jan 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·D KitayapornT D Mastro
Jan 1, 1995·Emerging Infectious Diseases·D Satcher
Jan 1, 1995·Emerging Infectious Diseases·S S Morse

❮ Previous
Next ❯

Citations

Oct 8, 1998·Journal of Urban Health : Bulletin of the New York Academy of Medicine·P W Ewald
Sep 17, 1999·International Journal of Food Microbiology·D C Kilsby
Oct 18, 2002·Journal of Clinical Epidemiology·Wasim Maziak
Sep 18, 2008·Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment·A M Jaine
Mar 31, 1999·Proceedings. Biological Sciences·S L MessengerJ J Bull
Feb 9, 2012·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Mark Achtman
Nov 21, 1997·Emerging Infectious Diseases·R L Hall
Dec 10, 2013·Disease-a-month : DM·Robin B McFee
Sep 8, 2010·Annals of Epidemiology·Chris Reiber, Janice Moore
Feb 24, 2009·Annals of Epidemiology·Chris Reiber
Jun 1, 2005·Biological Reviews of the Cambridge Philosophical Society·Miriam BrandtJürgen Heinze
Feb 3, 2005·Biological Reviews of the Cambridge Philosophical Society·Bruno A Walther, Paul W Ewald
Jun 14, 2005·Social Science & Medicine·Carol M Worthman, Brandon Kohrt
Dec 4, 2012·Lancet·Stephen S MorsePeter Daszak
Mar 1, 2007·FEMS Microbiology Reviews·Peter van BaarlenBart P H J Thomma
May 29, 2003·Chemistry & Biology·Suzanne Beckham ShukerKelly J Dennison
May 29, 2016·EcoHealth·Bruce A RideoutPeter J Hudson
Feb 1, 2014·Evolution, Medicine, and Public Health·James J Bull, Michael Turelli
Oct 16, 2004·Journal of Cellular Biochemistry·Simone Cristina Olenscki GilliSara Teresinha Olalla Saad
Jun 30, 2007·Evolution; International Journal of Organic Evolution·Richard H Heineman, James J Bull
Nov 23, 2007·Critical Reviews in Microbiology·Michael Greger
Jul 4, 2020·The European Physical Journal. E, Soft Matter·Andreas Eilersen, Kim Sneppen
Feb 1, 2013·Emerging Microbes & Infections·Anneke EngeringJan Slingenbergh
Apr 11, 2018·Evolutionary Applications·Michael Kosoy, Roman Kosoy
May 22, 2002·Bioorganic Chemistry·Julie J HaSuzanne Beckham Shuker
Oct 12, 2016·Microbiology Spectrum·Steven E Massey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.